VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VYCOR MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.07+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.24M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0570 (−45.97%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
VYCOR MEDICAL INC grew revenue 1.6% to $1.81M over the twelve months to Jun 30, 2026. Operating income rose 113.8% to $48.22K, moving the operating margin from 1.3% to 2.7%. Free cash flow was -$18.70K, down 134.1% from a year earlier.
Revenue
$1.81M
+1.6% vs. a year earlier
Operating income
$48.22K
+113.8% vs. a year earlier
Free cash flow
-$18.70K
-134.1% vs. a year earlier
EPS, diluted
$0.00
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.24M
- P/E ratio
- –
- Price to sales
- 1.24
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -0.84%
Fundamentals
- Revenue
- $1.81M
- Net income
- -$59.93K
- EPS, diluted
- $0.00
- Free cash flow
- -$18.70K
- Book value per share
- -$0.13
- Diluted shares
- 33M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$1.81M+1.6% YoY
Gross profit
$1.51M-1.2% YoY
Operating income
$48.22K+113.8% YoY
Net income
-$59.93K
EPS, diluted
$0.00
Free cash flow
–
Reported periodTrailing twelve months